Laboratori 2025/2026- Immunologia e Oncologia di Base e Applicate

Di seguito è possibile visionare l’elenco dei Supervisors (e i link ai rispettivi CV) e i progetti presentati per l' a.a. 2025/2026 all'interno del curriculum in Immunologia e Oncologia di Base e Applicate.

Nell'elenco sono riportate le borse a progetto e a seguire i progetti liberi tra cui i candidati, risultati idonei alla seconda fase di valutazione, dovranno scegliere i progetti di preferenza così come indicato nel bando.

7 BORSE A PROGETTO:

Borsa a progetto BAIO1: CENCI SIMONE

Unit: Age Related Diseases

BAIO 1:Immunogenic vulnerabilities against myeloma

Borsa a progetto BAIO2: IANNACONE MATTEO

Unit: Division of Immunology, Transplantation, and Infectious Diseases

BAIO2: Functional epigenetic remodeling of dysfunctional CD8+ T cells during chronic HBV infection

Borsa a Progetto BAIO 3: IANNACONE MATTEO

Unit: Division of Immunology, Transplantation, and Infectious Diseases

BAIO 3: The role of regulatory T (Treg) cells in the liver in health and disease

Project-Based Fellowship BAIO 4: LATORRE DANIELA

Unit: Neuroimmunology

BAIO 4: Analysis of autoreactive T cell immunity in inflammatory peripheral neuropathies

Borsa a Progetto BAIO 5: LATORRE DANIELA

Unit: Neuroimmunology

BAIO 5: Exploring unconventional T cells in autoummune neurological disorders

Borsa a Progetto BAIO 6: OSTUNI RENATO

Unit: Genomic of the Innate Immune System

BAIO 6: Synthetic biology platforms for myeloid cell engineering

Borsa a Progetto BAIO 7: TONON GIOVANNI

Unit: Functional Genomics of Cancer

BAIO 7: Targeting plasticity in metastatic pancreatic ductal adenocarcinoma

BRAGONZI ALESSANDRA

Unit: Infection and Cystic Fibrosis Unit

Gut-Lung axis in Cystic Fibrosis: pathophysiological basis for diagnostic and therapeutic approaches

CASORATI GIULIA

Unit: Experimental Immunology

MHC-Independent T Cell Therapies: Advancing CD1c-redirected adoptive cell therapy for Hematologic Malignancies

DE GIOVANNI MARCO

Unit: Immune Cell Migration and Regionalization Unit

Project1: Understanding the Regionalization of Intestinal Mucosa-Associated Lymphoid Tissues (MALTs) Project2: Analysis of newly recruited immune cells to tumors by sequential intravascular labeling and spectral flow cytometry.

DEGANO MASSIMO

Unit: Biocrystallography

Molecular basis of cell-autonomous signalling in chronic lymphocytic leukemia

GABELLINI DAVIDE

Unit: Gene Expression Regulation

Project1: Understanding and targeting the DUX4-r oncogenic pathway Project2: Proteolysis targeting chimera targeting the DUX4-r oncogene

GHIA PAOLO PROSPERO

Unit: B  CELL NEOPLASIA UNIT

Exploring TPL2 involvement in CLL pathogenesis

GREGORI SILVIA

Unit: Mechanisms of peripheral Tolerance Unit – SR-Tiget

Exploring and exploiting the tolerogenic potential of hematopoietic stem and progenitor cells

INVERSO DONATO

Unit: Vascular Pathobiology

Endothelial determinants of hcc heterogeneity

KUKA MIRELA

Unit: Dynamics of immune responses Unit

Characterization of B cell heterogeneity, dynamics, and function in breast cancer

LORE' NICOLA IVAN

Unit: Emerging Bacterial Pathogen Units

Exploring co-Infection and host interactions in chronic respiratory disease using In vitro, In vivo, and omics approaches

MANFREDI ANGELO 

unit: Autoimmunity and Vascular lnflammation

lnvestigating Pulmonary Megakaryocytes in experimental models of lnterstitial Lung Disease Associateci with Systemic Sclerosis.

MUZIO MARTA

Unit: Cell signaling Unit, division of experimental oncology

Understanding Toll-like receptor 10 function in B-cell lymphomas

OSTUNI RENATO

Unit: Genomic of the Innate Immune System

Spatial organization of the pancreatic tumor microenvironment

PIEMONTI LORENZO

Unit: Beta Cell Biology

Mesenchymal Stem Cells as a Dual-Action Strategy for Drug Delivery and Reprogramming of the Tumor Microenvironment

SCIELZO CRISTINA

Unit:  Malignant B cell biology and 3D modelling

Exploiting a comprehensive 3D model to recapitulate and study leukemic cells dissemination in-vitro

VAGO RICCARDO

Unit: Extracellular vesicles and toxins

Exploiting the potential of extracellular vesicles as drug delivery systems